Severe Acute Motor Axonal Neuropathy associated with Influenza-A (H1N1) Infection and Prolonged Respiratory Failure - A Case Report.
Guillain-Barre syndrome
acute motor axonal neuropathy
influenza virus A H1N1
nodopathy
prolonged respiratory failure
tetraplegia
Journal
Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)
ISSN: 2393-1809
Titre abrégé: J Crit Care Med (Targu Mures)
Pays: Poland
ID NLM: 101706934
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
26
02
2021
accepted:
29
07
2021
entrez:
22
12
2021
pubmed:
23
12
2021
medline:
23
12
2021
Statut:
epublish
Résumé
Acute Motor Axonal Neuropathy (AMAN) is an immune-mediated disorder of the peripheral nervous system, part of the spectrum of the Guillain-Barre syndrome (GBS). An infectious event most often triggers it reported a few weeks before the onset. The reported case is of a 56 years-old woman who developed acute motor axonal neuropathy three weeks after respiratory infection with influenza A virus subtype H1N1. Despite early treatment with plasmapheresis and intravenous immunoglobulins, the patient remained tetraplegic, mechanically ventilated for five months, with repetitive unsuccessful weaning trails. The probable cause was considered to be phrenic nerve palsy in the context of acute motor axonal neuropathy. This case highlights that acute motor axonal neuropathy is a severe and life-threatening form of Guillain-Barre syndrome associated with significant mortality and morbidity. Neurological and physical recovery strongly depend on the inter-professional effort in an intensive care unit and neurology professionals.
Identifiants
pubmed: 34934821
doi: 10.2478/jccm-2021-0030
pii: jccm-2021-0030
pmc: PMC8647670
doi:
Types de publication
Journal Article
Langues
eng
Pagination
302-307Informations de copyright
© 2021 Oana Mosora, Laura Barcutean, Rodica Balasa, Raluca Fodor, Smaranda Maier, Zoltan Bajko, Adina Stoian, Anca Motataianu, published by Sciendo.
Déclaration de conflit d'intérêts
Conflict of interest None to declare.
Références
Adv Exp Med Biol. 2019;1190:323-331
pubmed: 31760653
J Neurol Sci. 2016 Oct 15;369:159-164
pubmed: 27653883
J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1186-95
pubmed: 25699569
Neuroepidemiology. 2011;36(2):123-33
pubmed: 21422765
PLoS One. 2007 Apr 04;2(4):e344
pubmed: 17406668
Lancet. 1998 Aug 22;352(9128):635-41
pubmed: 9746040
J Neurosci. 2010 Mar 10;30(10):3555-66
pubmed: 20219989
Ann Neurol. 1996 Oct;40(4):635-44
pubmed: 8871584
J Neuroimmunol. 2011 Feb;231(1-2):70-2
pubmed: 20947177
Nefrologia. 2012;32(1):114
pubmed: 22294010
J Crit Care Med (Targu Mures). 2020 Jan 31;6(1):74-79
pubmed: 32104735
N Engl J Med. 2012 Jun 14;366(24):2294-304
pubmed: 22694000
Clin Neurophysiol. 2012 Aug;123(8):1487-95
pubmed: 22480600
Int J Neurosci. 2016 Nov;126(11):985-8
pubmed: 26335975
Neurol Neuroimmunol Neuroinflamm. 2019 May 21;6(4):e575
pubmed: 31355311
Neuroepidemiology. 2009;32(2):150-63
pubmed: 19088488
Neurology. 2002 Feb 12;58(3):476-8
pubmed: 11839856
IDCases. 2017 Dec 16;11:36-38
pubmed: 29387550
J Neurol Sci. 2012 Jan 15;312(1-2):173-6
pubmed: 22000408
Neurocrit Care. 2010 Aug;13(1):98-100
pubmed: 20428968
Lancet. 2013 Apr 27;381(9876):1461-8
pubmed: 23498095
Neurology. 2013 Apr 30;80(18):1650-4
pubmed: 23576619
Eur J Neurol. 2009 Apr;16(4):e81
pubmed: 19222546
Brain. 2007 Sep;130(Pt 9):2245-57
pubmed: 17337484
Hum Vaccin Immunother. 2018;14(11):2568-2579
pubmed: 29953326
J Neurosci Rural Pract. 2017 Jan-Mar;8(1):68-73
pubmed: 28149085
Neurology. 2008 Apr 29;70(18):1608-13
pubmed: 18443311
Nat Rev Neurol. 2014 Aug;10(8):469-82
pubmed: 25023340
Lancet. 2016 Aug 13;388(10045):717-27
pubmed: 26948435
CNS Spectr. 2008 Sep;13(9):744-6
pubmed: 18849892
Lancet. 2011 Oct 29;378(9802):1545-6
pubmed: 22035553
Cureus. 2018 Apr 20;10(4):e2511
pubmed: 29930889